PRAC met from July 6-9, 2026, to review medicine risks. It found a small meningioma increase with prolonged contraceptive use. One additional case is estimated per 67,300 women using these medicines. PRAC recommended contraindications, monitoring advice, warnings, and healthcare communications. The overall likelihood remains very low despite the identified increase.
Why Do PRAC, FAERS, and drug safety Change Work?
Postmarketing and epidemiological evidence suggested a small increased meningioma risk after prolonged use. PRAC recommended updated product information, contraindications, monitoring, and a direct healthcare professional communication. EMA estimated one additional meningioma for every 67,300 women using the medicines.
Impact Across PRAC, FAERS, and drug safety
Positive effect: Clearer warnings can support informed prescribing, earlier symptom recognition, and appropriate discontinuation. Risk: Risk communication may cause confusion if teams fail to explain that the absolute likelihood remains very low. Implementation challenge: Companies must coordinate consistent wording, implementation, medical responses, and local communications.
Career Skills for PRAC, FAERS, and drug safety
The update matters because it changes how organisations plan, document, communicate, or control regulated work. Professionals do not need to predict every outcome. They should understand the verified change, identify role impacts, and build evidence around the most relevant skills.
Across Regulatory Affairs: Practical Career Impact
Regulatory teams coordinate product-information changes and national implementation. Candidates should connect this impact with evidence from projects, training, placements, or regulated workplace responsibilities.
- Daily-work impact: Regulatory teams coordinate product-information changes and national implementation.
- Learn or review: variation management, SmPC wording, and implementation tracking.
Next Results After 1 per 67,300 users
The recommendations will move through EU decision processes and agreed communication plans. Professionals should monitor the official source, assess documented gaps, and prepare role-specific examples before interviews, audits, submissions, or implementation work.
Build context with Pharmacovigilance Interview Questions and Expert Answers and strengthen practical knowledge through Introduction to Pharmacovigilance.